Immune Response to CoronaVac and Its Safety in Patients with Type 2 Diabetes Compared with Healthcare Workers

Background: Vaccines for SARS-CoV-2 have been critical for preventing disease. Previous research showed patients with diabetes have impaired immunity. This study aimed to determine the immunity to coronavirus after CoronaVac by comparing patients with type 2 diabetes (T2D) and healthcare workers (HC...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Bothamai Dechates, Thachanun Porntharukchareon, Supamas Sirisreetreerux, Phonthip Therawit, Supanat Worawitchawong, Gaidganok Sornsamdang, Kamonwan Soonklang, Kriangkrai Tawinprai
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2023-03-01
Schriftenreihe:	Vaccines
Schlagworte:	diabetes mellitus CoronaVac Sinovac anti-RBD immunoglobulin
Online-Zugang:	https://www.mdpi.com/2076-393X/11/3/684
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!